Search - tctmd.com

Displaying 61 - 80 of 116

Sort: Relevancy | Date

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Industry News

Tianjin & AstraZeneca Collaborate On Cardiovascular Disease

May 19, 2014

News Industry News

Medtronic Applauds AACE/ACE on Their Updated Insulin Pump Therapy Consensus Statement

May 19, 2014

News Industry News

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

May 06, 2014

News Industry News

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

News Industry News

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

February 13, 2014

News Industry News

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

October 31, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Industry News

FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries

September 24, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

News Industry News

Medtronic Submits First 'PMA' Module for IN.PACT Admiral Drug-Eluting Balloon

August 15, 2013

News Industry News

PTS, Inc. Introduces CardioChek® Plus Analyzer

July 30, 2013

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

News Industry News

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

May 21, 2013

News Industry News

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 21, 2013

News Industry News

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 11, 2013

News Industry News

FDA Approves Longer Lengths of Medtronic’s Resolute Integrity Stent

February 24, 2013

News Industry News

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

December 16, 2012

Advertisement

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Tianjin & AstraZeneca Collaborate On Cardiovascular Disease

Medtronic Applauds AACE/ACE on Their Updated Insulin Pump Therapy Consensus Statement

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

Medtronic Submits First 'PMA' Module for IN.PACT Admiral Drug-Eluting Balloon

PTS, Inc. Introduces CardioChek® Plus Analyzer

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

FDA Approves Longer Lengths of Medtronic’s Resolute Integrity Stent

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content